Description
| Specialty | COARAVEN |
|---|---|
| Dosage | 300 mg, 12.5 mg |
| Form | Film-coated tablet |
| Presentation | B/30 |
| Primary packaging | Blister |
| Specification | White opaque PVC/PVDC/Alu |
| INN | HYDROCHLOROTHIAZIDE, IRBESARTAN |
| VEIC Classification | Essential |
| Therapeutic Class | CARDIOVASCULAR SYSTEM |
| Subclass | AGENTS ACTING ON THE RENIN–ANGIOTENSIN SYSTEM |
| Laboratory | PHILADELPHIA PHARMA |
| Schedule | A |
| Shelf life | 24 (months) |
| Generic/Brand | Generic |
| Marketing Authorization Number | 9353044 |
| Marketing Authorization Date | 2014-03-14 |
| Range | Cardio-Metabolic |
Reviews
There are no reviews yet.